These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1325 related articles for article (PubMed ID: 32194878)
1. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878 [TBL] [Abstract][Full Text] [Related]
2. Bilateral Cochlear Implantation: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2018; 18(6):1-139. PubMed ID: 30443278 [TBL] [Abstract][Full Text] [Related]
3. The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model. Bond M; Mealing S; Anderson R; Elston J; Weiner G; Taylor RS; Hoyle M; Liu Z; Price A; Stein K Health Technol Assess; 2009 Sep; 13(44):1-330. PubMed ID: 19799825 [TBL] [Abstract][Full Text] [Related]
4. Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2020; 20(4):1-85. PubMed ID: 32190165 [TBL] [Abstract][Full Text] [Related]
5. Hearing Instruments for Unilateral Severe-to-Profound Sensorineural Hearing Loss in Adults: A Systematic Review and Meta-Analysis. Kitterick PT; Smith SN; Lucas L Ear Hear; 2016; 37(5):495-507. PubMed ID: 27232073 [TBL] [Abstract][Full Text] [Related]
6. Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2019; 19(7):1-126. PubMed ID: 31911825 [TBL] [Abstract][Full Text] [Related]
7. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487 [TBL] [Abstract][Full Text] [Related]
8. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant. Sprinzl G; Toner J; Koitschev A; Berger N; Keintzel T; Rasse T; Baumgartner WD; Honeder C; Magele A; Plontke S; Götze G; Schmutzhard J; Zelger P; Corkill S; Lenarz T; Salcher R Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1565-1579. PubMed ID: 36625869 [TBL] [Abstract][Full Text] [Related]
9. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study. den Besten CA; Monksfield P; Bosman A; Skarzynski PH; Green K; Runge C; Wigren S; Blechert JI; Flynn MC; Mylanus EAM; Hol MKS Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of one-year outcomes after cochlear implantation in adults with single-sided deafness]. Chen JY; Chen B; Shi Y; Zhang LF; Gao ZC; Kong Y; Li YX Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jun; 59(6):602-613. PubMed ID: 38965850 [No Abstract] [Full Text] [Related]
11. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251 [TBL] [Abstract][Full Text] [Related]
12. Clinical performance, safety, and patient-reported outcomes of an active osseointegrated bone-conduction hearing implant system at 24-month follow-up. Cowan R; Lewis AT; Hallberg C; Tong MCF; Birman CS; Ng IH; Briggs R Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):683-691. PubMed ID: 37552281 [TBL] [Abstract][Full Text] [Related]
13. Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2023; 23(9):1-293. PubMed ID: 39364436 [TBL] [Abstract][Full Text] [Related]
14. Clinical Performance, Safety, and Patient-Reported Outcomes of an Active Osseointegrated Steady-State Implant System. Briggs R; Birman CS; Baulderstone N; Lewis AT; Ng IHY; Östblom A; Rousset A; Tari S; Tong MCF; Cowan R Otol Neurotol; 2022 Aug; 43(7):827-834. PubMed ID: 35878640 [TBL] [Abstract][Full Text] [Related]
15. A cost-utility analysis of cochlear implants for single sided deafness in adults and children in the Netherlands. van Lieshout C; Abraham K; Smit AL; Frederix GWJ PLoS One; 2024; 19(8):e0307881. PubMed ID: 39102399 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes. Cywka KB; Skarzynski PH; Krol B; Hatzopoulos S; Skarzynski H Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3525-3534. PubMed ID: 35182185 [TBL] [Abstract][Full Text] [Related]
17. Hearing performance in single-sided deaf cochlear implant users after upgrade to a single-unit speech processor. Mertens G; Hofkens A; Punte AK; De Bodt M; Van de Heyning P Otol Neurotol; 2015 Jan; 36(1):51-60. PubMed ID: 25406874 [TBL] [Abstract][Full Text] [Related]
18. A comparative study on speech in noise understanding with a direct acoustic cochlear implant in subjects with severe to profound mixed hearing loss. Lenarz T; Verhaert N; Desloovere C; Desmet J; D'hondt C; González JC; Kludt E; Macías AR; Skarżyński H; Van de Heyning P; Vyncke C; Wasowski A Audiol Neurootol; 2014; 19(3):164-74. PubMed ID: 24556905 [TBL] [Abstract][Full Text] [Related]